Know Cancer

or
forgot password

CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA


N/A
18 Years
66 Years
Open (Enrolling)
Both
Acute Myeloid Leukemia

Thank you

Trial Information

CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA

Inclusion Criteria


Patients with acute myeloid leukemia (<=66 years), treated with conventional and
experimental chemotherapy following allogeneic transplantation. THis patients have been
enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

Overall survival

Outcome Time Frame:

1 year

Safety Issue:

Yes

Principal Investigator

Benedetto Bruno, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Divisione di Ematologia-Città della Salute e della Scienza di Torino

Authority:

Italy: Ministry of Health

Study ID:

AML-TO-2012

NCT ID:

NCT01785953

Start Date:

February 2013

Completion Date:

February 2014

Related Keywords:

  • Acute Myeloid Leukemia
  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Myeloid

Name

Location